Emergent BioSolutions Reports Third Quarter 2023 Financial Results

<p>Third Quarter 2023 Total Revenues of $271M, above the prior guidance range Third Quarter 2023 Pre-Tax Loss of  $(266)M and Adjusted EBITDA(2) of $20M Updates FY 2023 guidance GAITHERSBURG, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported selected financial results for the third quarter ended September 30, 2023. The selected […]</p>
<p>The post <a href="https://forextv.com/top-news/emergent-biosolutions-reports-third-quarter-2023-financial-results/">Emergent BioSolutions Reports Third Quarter 2023 Financial Results</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>